Muscle & Nerve · 2005 · 12 citations · 30 references
Life SciencesImmunologyPathologyApoptosisAutoimmunityImmunopathologyAutoantibodiesAutoimmune Disease PathologyMuscle DisordersMuscle PathologyMuscle PhysiologyMuscle StructureAnti-acetylcholine Receptor AntibodiesCell MorphologyCell Morphology AnalysisIntracellular Inclusion BodiesIntracytoplasmic Inclusion BodiesTissue Autoantibodies
Myasthenia gravis (MG) is caused primarily by autoantibodies against the nicotinic acetylcholine receptor (AChR), but autoantibodies to other muscle proteins may be present. Many of these proteins have structural or signalling functions, the disruption of which may affect muscle cell morphology or viability. In order to investigate the role of such autoantibodies in MG, we examined the effect of MG patient sera, of different autoantibody composition and obtained at different stages of disease severity, on primary human muscle cells. Sera from MG patients induced changes in cell morphology from typical elongated cells to an irregular phenotype, caused the formation of inclusion bodies and intracellular vesicles, and led to a disordered arrangement of actin microfilaments. Sera from the most severely affected patients also induced cell death, which did not occur via classic apoptosis. The effects were not complement-mediated and were dose- and time-dependent. As the effects observed in the cell culture system correlated with disease severity, a greater understanding of the individual factors responsible for these effects may improve our understanding of MG pathogenesis and be of value in the assessment of disease in individual patients.
30
Antibody to acetylcholine receptor in myasthenia gravis
Jon Lindstrom, Marjorie E. Seybold, Vanda A. Lennon et al. · Neurology · 1976 · 1.2K citations · Full text
Life Sciences, Immunology, Neurology +12
Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis
Amelia Evoli · Brain · 2003 · 613 citations
Medicine, Immunology, Pathology +15